A recent systematic review found the use of GLP-1 agonists in people with binge eating disorder reduced behavioural and cognitive symptoms associated with binge eating
5 things to know before switching to the new weight loss pill KK Stock // Shutterstock Glucagon-like peptide-1 (GLP-1) medications, such as Wegovy (semaglutide), have helped many people lose weight
Are currently taking another GLP-1 receptor agonist or another semaglutide-containing product
Take a look: Marsh McLennan Agency Teladoc Health #EmployeeBenefits #ObesityCare #WorkplaceWellbeing Why obesity care strategies must go beyond GLP1s to drive sustainable outcomes To view or add a comment, sign in Here is another discussion from Behind the Claims with Scott & Ryan (podcast) from Health Care Administrators Association (HCAA) Executive Forum
And when that happens, there will be no manufacturer to sue, no pharmacy to discipline, and no regulator to answer for it
Once approved, in-network pharmacy access may be limited, forcing patients to use mail-order services or travel distance to fill prescriptions, reducing convenience and adherence
